Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801772 · ClinicalTrials.gov registry record · NA
Effects of a Metronome on Functional Outcomes in Aquatic Therapy
A NA study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03801772 is a NA study that has completed, run by Aultman Health Foundation. The registered enrollment target is 100 participants.
The verdict
NCT03801772, a NA study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of a pacing device, a metronome, improves functional outcome measures in aquatic therapy when compared to a control group.
Interventions
- DEVICE Metronome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-01-21 |
| Est. Completion | 2021-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801772
The ClinicalTrials.gov registry entry for NCT03801772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metronome is the first listed.
NCT03801772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801772 about?
NCT03801772 is a clinical study titled "Effects of a Metronome on Functional Outcomes in Aquatic Therapy". The purpose of this study is to determine if the use of a pacing device, a metronome, improves functional outcome measures in aquatic therapy when compared to a control group.
What is the current status of trial NCT03801772?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-01-21. Estimated completion is 2021-04-16.
What interventions are being tested in trial NCT03801772?
The interventions under investigation include: Metronome (DEVICE).
Who is sponsoring clinical trial NCT03801772?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.